Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rhabdomyosarcoma × Interleukin-2 × Clear all

Sponsor

Conditions

Melanoma 33 Neoplasm Metastasis 16 Leukemia, Myeloid, Acute 11 Skin Neoplasms 9 Leukemia 9 Kidney Neoplasms 9 Carcinoma, Renal Cell 9 Neoplasms 7 Ovarian Neoplasms 6 Breast Neoplasms 6 Lymphoma 5 Lymphoma, Non-Hodgkin 4 Congenital Abnormalities 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neuroblastoma 3 Myelodysplastic Syndromes 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Recurrence 2 Papillomavirus Infections 2 Lymphoma, Mantle-Cell 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vulvar Diseases 1

Interventions

Irinotecan 7 Cyclophosphamide 7 Vincristine 6 Dactinomycin 5 temsirolimus 4 cixutumumab 4 Sirolimus 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Etoposide 4 X-Rays 3 Radiation 3 Phantoms, Imaging 3 Doxorubicin 3 thymoglobulin 2 fludarabine phosphate 2 eribulin 2 Vinorelbine 2 Temozolomide 2 Tacrolimus 2 Stem Cell Transplantation 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Image-Guided 2 Peripheral Blood Stem Cell Transplantation 2 Nuclear Medicine Department, Hospital 2 Nivolumab 2 Melphalan 2 Ifosfamide 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡